Programma - III Congresso Nazionale della Società Italiana per lo
Programma - III Congresso Nazionale della Società Italiana per lo
Programma - III Congresso Nazionale della Società Italiana per lo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Milano, 30 novembre - 2 dicembre 2007<br />
Università degli Studi di Milano<br />
<strong>Programma</strong>
X<strong>III</strong> CONGRESSO ITALIANO<br />
DELLA FIBROSI CISTICA<br />
<strong>III</strong> CONGRESSO NAZIONALE SIFC<br />
Milano, 30 novembre – 2 dicembre 2007<br />
Università degli Studi di Milano<br />
Via Festa del Perdono, 7<br />
PRESIDENTE ONORARIO<br />
Annamaria Giunta<br />
PRESIDENTE<br />
Carla Co<strong>lo</strong>mbo<br />
COMITATO SCIENTIFICO<br />
Ferruccio Bonino, Cesare Braggion, Francesco Blasi, Massimo Conese,<br />
Valeria Raia, Francesca Alatri, Filippo Festini, Rolando Gagliardini,<br />
Manuela Seia, Giovanni Taccetti<br />
COMITATO ORGANIZZATORE<br />
Diana Costantini, Rita Nobili, Manuela Seia, Lisa Cariani, Valeria<br />
Daccò, Maria Chiara Russo<br />
SEGRETERIA ORGANIZZATIVA<br />
eac srl – Via Sannio, 4 – 20137 Milano- tel +390259902320 – fax<br />
+390259900758 – e-mail eacsrl@tin.it
Venerdì 30 Novembre<br />
Aula: Aula: A – Po<strong>lo</strong> Scientifico – Policlinico<br />
Workshop del Gruppo Professionale dei Fisioterapisti e TNPEE<br />
Coordinano: M. Cornacchia (Verona) e U. Pradal (Verona)<br />
8.00-14.00 Corso teorico pratico di ventilazione non invasiva<br />
Modifiche dei parametri meccanici del polmone con FC<br />
U. Pradal (Verona)<br />
Tipo<strong>lo</strong>gie di ventilazione in FC<br />
M. Damin (Padova)<br />
Impostazione di un ventilatore<br />
M. Damin (Padova)<br />
Ruo<strong>lo</strong> del Fisioterapista nella NIV<br />
A. Brivio (Milano)<br />
Applicazione di NIV nel paziente con fibrosi cistica: discussione di un<br />
caso clinico<br />
C. Tartali (Verona)<br />
Prove pratiche sulle apparecchiature ed interfacce a piccoli gruppi<br />
Aula: Aula: Borghi – Policlinico<br />
Workshop del Gruppo Professionale degli Infermieri e Infermieri<br />
Pediatrici<br />
Coordinano: S. Ballarin (Verona) e C. Loganes (Trieste)<br />
8.00-14.00 L’infermieristica basata sulle evidenze e l’assistenza alla<br />
<strong>per</strong>sona affetta da Fibrosi Cistica: ricerca, aggiornamento e<br />
implementazione <strong>della</strong> buona pratica clinica<br />
EBN e ricadute sull’assistenza infermieristica<br />
F. Festini (Firenze)<br />
Gli standard inglesi <strong>per</strong> l’assistenza infermieristica<br />
I. Milella (Bari)<br />
La comunicazione nell’équipe: assertività e gestione del conflitto<br />
S. Ferens (Verona)<br />
Accompagnamento alla scelta <strong>della</strong> genitorialità<br />
F. Gaudino (Verona)<br />
La <strong>per</strong>sona affetta da FC che sceglie di diventare genitore<br />
S. Ballarin (Verona)
Aula: Devoto – Clinica del Lavoro<br />
Workshop del Gruppo del test del sudore<br />
Coordina: N. Cirilli (Ancona)<br />
8.00-14.00 Workshop teorico pratico sul test del sudore: aggiornamento<br />
delle conoscenze scientifiche<br />
Test del sudore: Update delle conoscenze scientifiche e<br />
raccomandazioni internazionali<br />
N. Cirilli (Ancona)<br />
Fase pre-analitica<br />
G. Mergni (Firenze)<br />
Fase analitica<br />
A. Borruso (Verona)<br />
Interpretazione dei risultati<br />
V. Raia (Napoli)<br />
Dimostrazione pratica<br />
V. Consalvo (Milano)<br />
Aula: C – Po<strong>lo</strong> Scientifico – Policlinico<br />
Workshop del Gruppo Professionale degli Psico<strong>lo</strong>gi<br />
Coordinano: P. Tabarini (Roma) e R. Nobili (Milano)<br />
8.00-14.00 La psico<strong>lo</strong>gia: dalla ricerca alla pratica clinica<br />
Designing a psycho<strong>lo</strong>gical study: light and shade<br />
A. Quittner (Miami, USA)<br />
Psycho<strong>lo</strong>gical variables as primary outcome<br />
A. Quittner (Miami, USA)<br />
Formulazione e validazione di ipotesi in studi che analizzano<br />
variabili psico<strong>lo</strong>giche<br />
R. Nobili (Milano)<br />
Il vissuto del paziente relativo al control<strong>lo</strong> delle infezioni<br />
P. Catastini (Firenze)<br />
Gli aspetti psicosociali dei caregivers dei pazienti affetti da fibrosi<br />
cistica<br />
F. Gobbi (Cesena), F. Lupi (Bo<strong>lo</strong>gna)
Aula: Sforza –Policlinico<br />
Workshop del Gruppo Professionale dei Microbio<strong>lo</strong>gi<br />
8.00-14.00 Il ruo<strong>lo</strong> del microbio<strong>lo</strong>go in fibrosi cistica fra diagnostica,<br />
ricerca, modelli organizzativi e formazione<br />
Coordina: S. Campana (Firenze)<br />
Staphy<strong>lo</strong>coccus aureus in fibrosi cistica: antibiotico-resistenza,<br />
“agr-group” e determinanti di virulenza<br />
S. Stefani (Catania)<br />
Il monitoraggio immuno<strong>lo</strong>gico dell’infezione da Pseudomonas<br />
aeruginosa<br />
L. Cariani (Milano), S. Campana (Firenze)<br />
Isolamento, identificazione e significato clinico di As<strong>per</strong>gillus spp.,<br />
Scedosporium spp. Ed altri funghi filamentosi in FC<br />
G. Manno (Genova)<br />
Valutazione esterna di qualità in FC: uno studio pi<strong>lo</strong>ta<br />
M.L. Garlaschi (Milano)<br />
Un model<strong>lo</strong> organizzativo di laboratorio <strong>per</strong> la fibrosi cistica<br />
E. Fiscarelli (Roma)<br />
L’es<strong>per</strong>ienza all’estero <strong>per</strong> la formazione in microbio<strong>lo</strong>gia <strong>della</strong><br />
fibrosi cistica<br />
P. Cocchi (Firenze)
Aula Magna dell’Università<br />
Workshop del Gruppo Professionale dei Pediatri<br />
Coordinano: V. Lucidi (Roma) e G. Magazzù (Messina)<br />
8.00-14.00 EuroCareCF workshop<br />
Dall’Evidence Based Medicine all’Evidence Based Practice<br />
From Evidence Based Medicine to Evidence Based Practice<br />
Data Mining - Recu<strong>per</strong>o delle informazioni ottenute tramite RCT.<br />
Metodi innovativi disponibili <strong>per</strong> l’informazione e la formazione<br />
scientifica<br />
Data mining - Information retrieval by RCT – New methods for<br />
scientific information and training.<br />
A. Tozzi (Roma)<br />
Dalla ricerca alla pratica. La validità esterna degli RCT<br />
From research to clinical practice. External validity of RCT<br />
L. Pagliaro (Palermo)<br />
Un esempio di analisi critica <strong>della</strong> letteratura: il progetto CAIRO<br />
An example of critical review and appraisal of the scientific<br />
literature from CF registries: The CAIRO project (Comparative Analysis<br />
of International CF Registries Overviewed).<br />
R. Buzzetti (Bergamo)<br />
Clinical database: uno strumento <strong>per</strong> misurare processi ed esiti<br />
assistenziali<br />
Clinical database: a tool to measure processes and outcomes.<br />
A. Cartabel<strong>lo</strong>tta (Bo<strong>lo</strong>gna)<br />
Sorveglianza delle reazioni avverse a farmaci e risk management<br />
Surveillance of adverse reaction to drugs and risk management.<br />
A. Caputi (Messina)<br />
Implementazione degli standard assistenziali: quali ostacoli?<br />
Evidence based medicine - one aid in providing good CF care.<br />
J. Littlewood (Leeds, UK)<br />
Prospettive future e conclusioni da parte dei relatori coordinate da<br />
Future <strong>per</strong>spectives and conclusion.<br />
G. Magazzù (Messina)<br />
14.00-15.30 Assemblea Generale dei Soci SIFC<br />
15.30-16.30 CERIMONIA INAUGURALE DEL CONGRESSO<br />
16.30-17.00 Party di Benvenuto
Aula Magna dell’Università<br />
1 a SESSIONE<br />
17.00-19.30 RICERCA DI BASE<br />
Moderatori: V. De Rose (Torino), M. Conese (Foggia)<br />
A new model of CF disease: No F508 No kinase<br />
A. Mehta (Dundee, UK)<br />
Secrezione CFTR-dipendente nel fegato<br />
M. Strazzabosco (New Haven, USA)<br />
New frontiers in gene therapy of Cystic Fibrosis<br />
U. Griesenbach (London, UK)<br />
New drugs to correct the basic CF defect<br />
D. N. Sheppard (Bristol, UK)
Sabato 1 Dicembre<br />
8.30-18.00 A<strong>per</strong>tura Seggio elettorale <strong>per</strong> rinnovo cariche SIFC<br />
Aula Magna dell’Università<br />
8.30-12.00 2 a SESSIONE<br />
LA RICERCA TRASLAZIONALE BIOMEDICA PER LE NUOVE CRONICITÀ:<br />
IL MODELLO DELLA FIBROSI CISTICA<br />
TRANSLATIONAL MEDICINE IN CHRONIC DISEASES: THE MODEL OF<br />
CYSTIC FIBROSIS<br />
ERS SYMPOSIUM<br />
Moderatori: C. Co<strong>lo</strong>mbo (Milano), F. Blasi (Milano)<br />
Clinical epidemio<strong>lo</strong>gy: the European Cystic fibrosis Registry<br />
A. Mehta (Dundee, UK)<br />
Of mice and men: early airway wall disease in cystic fibrosis<br />
A. Bush (London, UK)<br />
Pharmacogenomics in cystic fibrosis<br />
L.J. Galietta (Genova)<br />
From the bench to the bed side: modulation of inflammation in<br />
cystic fibrosis<br />
F. Ratjen (Toronto, Canada)<br />
Bone and cystic fibrosis: impact of chronic inflammation<br />
F. De Benedetti (Roma)<br />
Exp<strong>lo</strong>iting genomics to deve<strong>lo</strong>p new antibiotics and vaccines<br />
against CF-related pathogens<br />
G. Doering (Tubingen, D)<br />
12.00-13.00 Pranzo e visita all’area Poster<br />
13.00-14.30 SESSIONE DI POSTER SELEZIONATI SU RICERCA CLINICA E DI BASE
Aula Magna dell’Università<br />
14.30-18.00 3 a SESSIONE<br />
LA RICERCA CLINICA<br />
Moderatori: D. Costantini (Milano), C. Braggion (Firenze)<br />
Acido Docosoesaenoico (DHA) nella Fibrosi Cistica<br />
C. Agostoni (Milano)<br />
Towards a European clinical trial network<br />
K. De Boeck (Lovanio, BE)<br />
Monitoraggio <strong>della</strong> terapia anti-Pseudomonas nelle fasi precoci<br />
G. Taccetti (Firenze)<br />
Approcci innovativi <strong>per</strong> il diabete associato a Fibrosi Cistica<br />
L. Minicucci (Genova)<br />
Studio tobramicina <strong>per</strong> via inalatoria <strong>della</strong> SIFC: conclusioni e<br />
prospettive<br />
F. Marchetti (Trieste)<br />
Valutazione precoce <strong>della</strong> compromissione polmonare<br />
H.A. Tiddens (Rotterdam, NL)<br />
Overview of early treatment of Pseudomonas infection<br />
F. Ratjen (Toronto, Canada)<br />
European Cystic Fibrosis Society Consensus on genetic testing<br />
M.J. Schwarz (Manchester, UK)<br />
Aula Magna dell’Università<br />
18.00-19.00 SIMPOSIO FARMACOECONOMIA<br />
LE DUE FACCE DELLA MEDAGLIA: MEDICINA ED ECONOMIA IN<br />
FIBROSI CISTICA<br />
Moderatori: E. Bignamini (Torino), C. Co<strong>lo</strong>mbo (Milano)<br />
Evoluzione epidemio<strong>lo</strong>gia <strong>della</strong> fibrosi cistica<br />
R. Buzzetti (Bergamo)<br />
Ieri oggi e domani nella cura <strong>della</strong> fibrosi cistica<br />
F. Pardo (Palermo)<br />
Scenario farmaco-economico <strong>della</strong> fibrosi cistica<br />
C. Lucioni (Milano)<br />
19.00-19.30 Risultati Elezioni<br />
21.00 Cena Sociale
Domenica 2 dicembre<br />
Aula Magna dell’Università<br />
9.00-14.00 Riunioni post Congressuali dei Gruppi di Lavoro<br />
• Gruppo Professionale dei Dietisti<br />
• Gruppo Professionale Fisioterapisti<br />
• Gruppo di Lavoro sul Diabete in FC<br />
• Commissione Adulti<br />
• Gruppo di Lavoro “End of Life care”<br />
• Commissione sugli “standards of care”<br />
• Nuovo registro italiano: assemblea dei Direttori dei Centri<br />
• Riunione <strong>della</strong> Lega <strong>Italiana</strong> Fibrosi Cistica<br />
Aula: 208 – Università<br />
Workshop del Gruppo Professionale dei Genetisti<br />
Coordina: F. Torricelli (Firenze)<br />
9.00-14.00 Update delle conoscenze scientifiche <strong>per</strong> l’analisi molecolare del<br />
gene CFTR<br />
Revisione e aggiornamento dei “Modelli di analisi genetica <strong>per</strong> la<br />
Fibrosi Cistica”<br />
M. Seia (Milano)<br />
Verso la definizione di una tariffa unica <strong>per</strong> la Fibrosi Cistica<br />
E. Pe<strong>lo</strong> (Firenze)<br />
Geni Modificatori: <strong>lo</strong> stato dell’arte. Loro applicazione ed utilità in<br />
diagnostica<br />
C. Centrone (Firenze)
Pannel<strong>lo</strong><br />
Numero<br />
1 THE NINFEA PROJECT: ONE YEAR OF WORK<br />
D.Falciatore* L.Giannotta F.Piccolantonio., L.Ratclif**<br />
* family doctor ** U.O.S. Cystic Fibrosis Cerignola<br />
2 PROLONGING THE DURATION OF PERIPHERAL VENOUS CATHETERS IN<br />
CYSTIC FIBROSIS PEOPLE. RANDOMIZED CONTROLLED STUDY ON THE<br />
EFFECT OF DIFFERENT CONCENTRATIONS OF ANTIBIOTICS IN NORMAL<br />
SALINE.<br />
Festini F, Neri S, Taccetti G, Repetto T, Braggion C.<br />
Centro FC <strong>della</strong> Toscana, Ospedale Meyer, Università di Firenze<br />
3 HOME INTRAVENOUS ANTIBIOTIC THERAPY IN CYSTIC FIBROSIS<br />
PATIENTS<br />
Carmen Zappa, Ada Raimondi<br />
Centro di Riferimento <strong>per</strong> la Fibrosi Cistica Regione Lombardia<br />
Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena - Milano<br />
4 THE CAIRO PROJECT (COMPARATIVE ANALYSIS OF INTERNATIONAL CF<br />
REGISTRIES OVERVIEWED): ANALYSIS AND REVIEW OF THE SCIENTIFIC<br />
LITERATURE FROM CF REGISTRIES<br />
Salvatore D, Baldo E, Forneris MP, Furnari ML, Lucidi V, Manunza D, Marinelli I, Messore<br />
B, Neri AS, Raia V, Buzzetti R, Mastella G.<br />
Italian CF Research Foundation, Verona, Italy.<br />
5 USE OF NIV IN THE DRAINING THERAPY: CLINICAL CASE<br />
Ciciretti Maria Antonietta - Luigi Ratclif<br />
UOS Cystic Fibrosis Cerignola<br />
6 COMPARISON OF HIGH FREQUENCY CHEST WALL OSCILLATION<br />
(HFCWO) AND PEP-MASK IN HOSPITALIZED PATIENTS WITH CYSTIC<br />
FIBROSIS (CF)<br />
F.Alatri; B.Giacomodonato; T.Perelli; L.Graziano; M.Varchetta; G.Cimino; L.Locorriere;<br />
E.Bonci; S.Quattrucci.<br />
Centro Fibrosi Cistica Regione Lazio, Roma<br />
7 EFFICACY OF HIGH FREQUENCY CHEST COMPRESSION (HFCC) IN THE<br />
CLEARANCE OF MUCUS IN PATIENTS WITH CYSTIC FIBROSIS (CF)<br />
V.Mazzotti, E.Balestri, S.Dall’Ara, F.Gobbi, F.Lupi, M.Ambroni, F.Battistini<br />
Centro Regionale Fibrosi Cistica - Cesena
8 AUTOMATION OF CFTR RE-SEQUENCING: TIME AND COSTS ANALYSIS<br />
Ferraguti G. 1,* , Pierandrei S. 1 , Bruno S.M. 1 , Ceci F. 1 , Di Gioia A. 1 , Quattrucci S. 2 ,<br />
Strom R. 1 , Lucarelli M. 1<br />
1,* Dept. of Cellular Biotechno<strong>lo</strong>gies and Hemato<strong>lo</strong>gy and 2 Dept. of Pediatrics, Regional CF<br />
Centre, “La Sapienza” University of Rome, Italy<br />
9 CYSTIC FIBROSIS MUTATIONS: GENOTYPE-PHENOTYPE RELATIONSHIP IN<br />
PATIENTS DIAGNOSED BY NEONATAL SCREENING.<br />
Irene Tardivo*, Aleksandar Veljkovic*, Cristiana Risso*, Gabriella Restagno§, Caterina<br />
Mari§, A.Lezo*, Elisabetta Bignamini*<br />
* Pediatric CF Center Piedmont and Valle d’Aosta – OIRM - Turin – Italy<br />
§ Molecular Genetics Service – OIRM – Turin – Italy<br />
10 CFTR MUTATION FREQUENCY IN CHILDREN DIAGNOSED BY NEONATAL<br />
SCREENING<br />
A. Veljkovic*, I. Tardivo*, G. Restagno§, I. Esposito*, G. Cordola*, E. Bignamini*<br />
* Pediatric CF Center Piedmont and Valle d’Aosta – OIRM - Turin – Italy<br />
§ Molecular Genetics Service – OIRM – Turin – Italy<br />
11 PHENOTYPIC VARIABILITY IN A FAMILY WITH PANCREATITIS AND CYSTIC<br />
FIBROSIS SHARING COMMON MILD CFTR MUTATION<br />
F. Alghisi 1 , A. Angioni 2 , A. C. Tomaiuo<strong>lo</strong> 2 , M. R. D’Apice 3 , S. Gambar<strong>della</strong> 3 , B. Russo 1 , S.<br />
Bella 1 , E. Fiscarelli 4 , G. Novelli 3 , V. Lucidi 1<br />
1<br />
U.O.S. of Cystic Fibrosis, Bambino Gesù Pediatric Hospital, Rome, Italy<br />
2<br />
Laboratory of Cytogenetics and Molecular Genetics, Bambino Gesù Pediatric Hospital,<br />
Rome, Italy<br />
3<br />
Dept. of Biopatho<strong>lo</strong>gy and Diagnostic Imaging, Tor Vergata University, Rome, Italy<br />
4<br />
Bacterio<strong>lo</strong>gy Laboratory, Bambino Gesù Pediatric Hospital, Rome, Italy<br />
12 DIAGNOSIS IN ATYPICAL CF: A CASE-REPORT TO LEARN<br />
Lucidi V. F. Alghisi 1 , A. Angioni 2 , A. C. Tomaiuo<strong>lo</strong> 2 , M. R. D’Apice 3 , B. Russo 1 , S. Bella 1 ,<br />
E. Fiscarelli 4 , G. Novelli 3 , V. Lucidi 1<br />
1<br />
U.O.S. of Cystic Fibrosis, Bambino Gesù Pediatric Hospital, Rome, Italy<br />
2<br />
Laboratory of Cytogenetics and Molecular Genetics, Bambino Gesù Pediatric Hospital,<br />
Rome, Italy<br />
3<br />
Dept. of Biopatho<strong>lo</strong>gy and Diagnostic Imaging, Tor Vergata University, Rome, Italy<br />
4<br />
Bacterio<strong>lo</strong>gy Laboratory, Bambino Gesù Pediatric Hospital, Rome, Italy
13 ATIPICAL CYSTIC FIBROSIS ASSOCIATED WITH COMPLEX ALLELE:<br />
DIAGNOSTIC AND MANAGEMENT DILEMMAS<br />
Polizzi AM. F. Alghisi 1 , A. Angioni 2 , A. C. Tomaiuo<strong>lo</strong> 2 , M. R. D’Apice 3 , B. Russo 1 , S.<br />
Bella 1 , E. Fiscarelli 4 , G. Novelli 3 , V. Lucidi 1<br />
1<br />
U.O.S. of Cystic Fibrosis, Bambino Gesù Pediatric Hospital, Rome, Italy<br />
2<br />
Laboratory of Cytogenetics and Molecular Genetics, Bambino Gesù Pediatric Hospital,<br />
Rome, Italy<br />
3<br />
Dept. of Biopatho<strong>lo</strong>gy and Diagnostic Imaging, Tor Vergata University, Rome, Italy<br />
4<br />
Bacterio<strong>lo</strong>gy Laboratory, Bambino Gesù Pediatric Hospital, Rome, Italy<br />
14 FROM ” EVOCATIVE” SYMPTOMS TO GENOTYPE DELTAF508/E831X.<br />
Caterina Di Girgenti 1 , Lucrezia Virruso 1 , Rosalia Messineo 1 , Antonina Cannuscio 1 , Lisa<br />
Termini 2 , Francesca Pardo 2 .<br />
1 2<br />
Molecolar Bio<strong>lo</strong>gy laboratory, Ospedale dei Bambini, Palermo, Italy, CF center, Ospedale<br />
dei Bambini, Palermo, Italy.<br />
15 A QUALITATIVE CHARACTERIZATION OF THE CFTR GENE BY mRNA<br />
ANALYSIS<br />
Costantino L 1 ., Paracchini V 1 ., Porcaro L 1 ., Di Cicco M 3 .,Monti A 2 ., C<strong>lo</strong>ut L 2 ., Capasso P 1 .,<br />
Degiorgio D 1 ., Coviel<strong>lo</strong> D 1 ., Co<strong>lo</strong>mbo C 2 ., Seia M 1 .<br />
1 Laboratory of Medical Genetics, 2 CF Center, 3 ENT Department Fondazione IRCCS<br />
Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy.<br />
16 IMPROVEMENT OF MOLECULAR TECHNOLOGIES AND PRENATAL<br />
DIAGNOSIS OF CYSTIC FIBROSIS<br />
Pe<strong>lo</strong> E 1 , Centrone C 1 , Giuliani C 1 , Repetto T 2 , ,Minuti B 1 , Torricelli F 1<br />
1. Centro di Riferimento Regionale <strong>per</strong> la Diagnosi Genetica di Fibrosi Cistica ,SOD<br />
Diagnostica Genetica AOU Careggi, Firenze<br />
2. Centro Regionale Toscano Fibrosi Cistica<br />
17 β-DEFENSIN-1 GENE POLYMORPHISMS IN CYSTIC FIBROSIS LUNG DISEASE<br />
Tesse Riccardina, Santostasi Teresa, Polizzi Angela, Mappa Luigi, Manca Antonio, De<br />
Robertis Francesco, Silecchia Ombretta, Logril<strong>lo</strong> Vito Pao<strong>lo</strong>, Armenio Lucio.<br />
Department of Biomedicina dell’Età Evolutiva, Pediatric Unit “S. Maggiore”, University of<br />
Bari, Italy.<br />
18 MUTATIONS AND POLYMORPHISM INTERFERING WITH PCR/OLA/SCS<br />
ASSAY<br />
1 A. Stamato, 1 F. Narzi, 1 A. Amato, 2 S. Pierandrei, 2 M. Lucarelli, 2 R. Strom, 1 S. Quattrucci, 1 L. Narzi<br />
1 Centro Fibrosi Cistica Regione Lazio - Clinica Pediatrica - 2 Dip. Biotecno<strong>lo</strong>gie Cellulari ed<br />
Emato<strong>lo</strong>gia – Università di Roma “La Sapienza”
19 DIRECT SEQUENCING OF CSTs IN CYSTIC FIBROSIS PATIENTS BEARING<br />
UNDEFINITE GENOTYPE<br />
Ausilia Elce, Rossella Tomaiuo<strong>lo</strong>, Ange<strong>lo</strong> Boccia, Giovanni Paolella and Giuseppe Castaldo<br />
CEINGE-Advanced Biotechno<strong>lo</strong>gies, scarl, Naples; Dept. of Biochemistry and Medical<br />
Biotechno<strong>lo</strong>gy, University of Naples “Federico II”.<br />
20 MOLECULAR ANALYSIS OF GENES ENCODING CFTR INTERACTORS OF<br />
SLC26 FAMILY IN CF PATIENTS: PRELIMINARY RESULTS<br />
Rossella Tomaiuo<strong>lo</strong>*, Giuseppe Cardil<strong>lo</strong>*, Ausilia Elce*, Chiara Bellia°, Valeria Raia # and<br />
Giuseppe Castaldo*<br />
*CEINGE-Advanced Biotechno<strong>lo</strong>gies, scarl, Naples; Dept. of Biochemistry and Medical<br />
Biotechno<strong>lo</strong>gy, University of Naples “Federico II”; °Lab. of Clinical Biochemistry, Faculty of<br />
Medicine, University of Palermo, Italy; # Dept. of Pediatrics, University of Naples “Federico II”.<br />
21 INVESTIGATION OF CFTR ESONIC REARRANGEMENTS IN INFERTILE<br />
COUPLES.<br />
Simona De Toffol 1 , Barbara Malvestiti 1 , Francesca Dulcetti 1 , Anna Ruggeri 1 , Andrea<br />
Maggioni 1 , Michele Di Lernia 1 , Federico Maggi 1 , Giuseppe Simoni 1 e Francesca R. Grati 1<br />
1 Research and Deve<strong>lo</strong>pment , Cytogenetics and Molecular Bio<strong>lo</strong>gy, TOMA Advanced<br />
Biomedical Assays S.p.A., Busto Arsizio, Varese<br />
22 EMERGING PATHOGENS IN CYSTIC FIBROSIS: TEN YEARS FOLLOW UP.<br />
Concetta Sciuto, Lucia Spicuzza, Giovanna Di Dio, Laura Bivona, Graziana Cassisi, Mario La<br />
Rosa<br />
Broncopneumo<strong>lo</strong>gia Pediatrica, Dipartimento di Pediatria, Università di Catania<br />
23 MOLECULAR EPIDEMIOLOGY OF STENOTROPHOMONAS MALTOPHILIA (SM)<br />
IN THE CYSTIC FIBROSIS (CF) CENTRE OF GENOVA .<br />
Mentatsti M., Morelli P., Melioli G. and Manno G.<br />
General Laboratory of Analysis, “Giannina Gaslini” Institute, Genova, Italy.<br />
24 EMERGENCE OF COLISTIN-RESISTANT PSEUDOMONAS AERUGINOSA FROM<br />
ITALIAN CYSTIC FIBROSIS PATIENTS<br />
Manno G. 1, Morelli P. 1, , Mentasti M. 1, , Casciaro R. 2 , Rossolini G.M. 3 , Cirilli N. 4,<br />
Gagliaridini R. 4, , D’Aprile A. 5 , Gioffrè F. 6 , Scuteri D. 6 , Melioli G. 1,<br />
1 Microbio<strong>lo</strong>gy Lab. 2 Cystic Fibrosis Centre- Gaslini Genova; 3 University of Siena; 4 Cystic<br />
Fibrosis Centre Ancona; 5 Microbio<strong>lo</strong>gy Lab. Cerignola; 6 Microbio<strong>lo</strong>gy Lab. Soverato.<br />
ITALY.
25 PSEUDOMONAS AERUGINOSA (PA) FROM CONTAMINATED SWIMMING<br />
POOLS: A SOURCE OF ACQUISITION FOR CYSTIC FIBROSIS (CF) PATIENTS?<br />
Morelli P. 1 , Mentasti M. 1 , Sangiu<strong>lo</strong> A. 2 , Arata L. 2 and G.Manno 1<br />
1 General Laboratory of Analysis “Giannina Gaslini” Institute, Genova, Italy; 2 ARPAL,<br />
Provincial Department, Genova, Italy.<br />
26 PERSISTANCE OF ACHROMOBACTER XYLOSOXIDANS IN CF PATIENTS:<br />
RESULTS OF A MOLECULAR STUDY<br />
N. Ravenni, P. Cocchi, S. Campana, C. Braggion.<br />
Cystic Fibrosis Center, Department of Paediatrics, University of F<strong>lo</strong>rence, F<strong>lo</strong>rence, Italy<br />
27 PSEUDOMONAS AERUGINOSA PRODUCING METALLO-β-LACTAMASES IMP-13<br />
IN A PATIENT WITH CYSTIC FIBROSIS<br />
Fiscarelli E. 1 , Lucidi V. 1 , Concato C. 1 , Pollini S. 2 , Mugnaioli C. 2 , Rossolini G.M. 2<br />
1 Fibrosi Cistica, Ospedale Bambin Gesù, Roma, 2 Sezione di Microbio<strong>lo</strong>gia, Dip. di Bio<strong>lo</strong>gia<br />
Molecolare, Università di Siena, Siena<br />
28 “AURORA’S CASE”<br />
P.Catastini, S.Magni, M.C. Cavicchi, T.Repetto, C.Braggion<br />
C.F.Center Meyer Hospital, F<strong>lo</strong>rence, Italy<br />
29 COMMUNICATION OF DIAGNOSIS TO CHILDREN: MEDICAL ROLE<br />
C. Risso, G. Cordola, I. Tardivo A. Veljkovic, Pediatric CF Centre, O.I.R.M. Turin, Italy.<br />
30 QUALITY OF LIFE IN ITALIAN PATIENTS WITH CYSTIC FIBROSIS (CF).<br />
Vincenzo di Ciommo§ MD, Eva Mazzotti§* PsyD, , Vincenzina Lucidi° MD, Sergio Bella°<br />
MD, Gianni Biondi^ , Marina Cuttini§ MD.<br />
§ Bambino Gesù Children’s Hospital, Epidemio<strong>lo</strong>gy Unit and ° CF Unit, Rome<br />
* Clinical Epidemio<strong>lo</strong>gy Unit, Dermato<strong>lo</strong>gical Institute IDI-IRCCS, Rome<br />
31 DNA METHYLATION ENHANCES REPAIR EFFICIENCY OF SMALL<br />
FRAGMENT HOMOLOGOUS REPLACEMENT (SFHR) GENE targetiNG<br />
1 2 1 1 1 2 1<br />
Filareto A., Ferraguti G., Malgieri A., Luchetti A., Spitalieri P., Strom R., Novelli G.,<br />
1 2,*<br />
Sangiuo<strong>lo</strong> F., Lucarelli M.<br />
1 2,*<br />
Dept. Biopatho<strong>lo</strong>gy, Tor Vergata University and Dept. Cellular Biotechno<strong>lo</strong>gies and<br />
Hemato<strong>lo</strong>gy, “La Sapienza” University - Rome, Italy
32 AZITHROMYCIN DECREASES ELEVATED GLUTATHIONE-S-TRANSFERASE<br />
T1 (GSTT1) AND M1 (GSTM1) EXPRESSION AND ACTIVITY IN CYSTIC<br />
FIBROSIS AIRWAY EPITHELIAL CELLS<br />
G Bergamini 1 *, C Cigana 1 *, C Sorio 2 , M Della Peruta 2 , BM Assael 1 , P Me<strong>lo</strong>tti 1<br />
1<br />
Cystic Fibrosis Center, Azienda Ospedaliera di Verona, Verona<br />
2<br />
Department of Pato<strong>lo</strong>gy, ,General Patho<strong>lo</strong>gy Section, University of Verona School of<br />
Medicine, Verona<br />
* The authors equally contributed to this work.<br />
33 MUDPIT ANALYSIS OF PSEUDOMONAS AERUGINOSA SECRETOME:<br />
CONSEQUENCES OF OXYGEN LIMITATION IN CLINICAL AND<br />
LABORATORY STRAINS<br />
C Cigana 1 *, G Bergamini 1 *, P Mauri 2 , C Sorio 3 , Di Silvestre D 2 , A Bragonzi 4 , BM Assael 1 , P<br />
Me<strong>lo</strong>tti 1<br />
1 Cystic Fibrosis Center-Azienda Ospedaliera Verona, Verona<br />
2 Institute for Biomedical Techno<strong>lo</strong>gies -CNR, Milan<br />
3 General Patho<strong>lo</strong>gy, University of Verona School of Medicine, Verona<br />
4 Institute for Ex<strong>per</strong>imental Treatment of CF, H.S. Raffaele, Milan<br />
* The authors equally contributed to this work.<br />
34 HOMING TO THE LUNG, MITOCHONDRIAL CONTENT AND CFTR<br />
EXPRESSION IN HEMATOPOIETIC STEM CELLS<br />
Conese M., 1,2 Rejman J., 2 Piro D., 1 Piccoli C., 1 Guerra L., 3 Lepore S., 1 Maffione A.B., 1<br />
D’Aprile A., 1 Favia M., 3 Copreni E., 2 Capitanio N., 1 Casavola V. 3<br />
1 Department of Biomedical Sciences, University of Foggia, Foggia; 2 Institute for the<br />
Ex<strong>per</strong>imental Treatment of Cystic Fibrosis, H.S: Raffaele, Milan; 3 Department of General<br />
and Environmental Physio<strong>lo</strong>gy, University of Bari, Bari, Italy.<br />
35 INFLUENCE OF PSEUDOMONAS AERUGINOSA ON THE GROWTH RATE AND<br />
INTERNALIZATION OF BURKHOLDERIA CENOCEPACIA<br />
L. Pirone 1,2 , S. Marinelli 1 , C. Auriche 1 , C. Dalmastri 2 , A. Bevivino 2* , F. Ascenzioni 1<br />
1 Dip. Bio<strong>lo</strong>gia Cellulare e del<strong>lo</strong> Sviluppo, Univ. "La Sapienza" (Rome); 2 Department of<br />
Biotechno<strong>lo</strong>gies, Agroindustry and Protection of Health, ENEA C.R. Casaccia (Rome)<br />
36 SELECTION AND ANALYSIS OF SILENCING RNA FOR EFFICIENT<br />
DOWNREGULATION OF ENaC CHANNEL IN LUNG EPITHELIAL CELLS<br />
Tilesi F., 1 Copreni E., 2 Melani R., 3 Fradiani P., 1 Castellani S., 2 Pedemonte N., 3 Caci E., 3<br />
Auriche C., 1 Galietta L.J.V., 3 Conese M., 2 Zegarra-Moran O., 3 Ascenzioni F. 1<br />
1 Department of Cellular and Deve<strong>lo</strong>pmental Bio<strong>lo</strong>gy, Sapienza University of Rome; 2 Institute<br />
for the Ex<strong>per</strong>imental Treatment of Cystic Fibrosis, H.S. Raffaele, Milan; Molecular Genetics<br />
Laboratory, Istituto G. Gaslini, Genova. Italy.
37 CAENORHABDITIS ELEGANS AND PSEUDOMONAS AERUGINOSA: A<br />
PATHOGENESIS MODEL IN CYSTIC FIBROSIS RESEARCH.<br />
D. Uccelletti 1 , S. Campana 2 , E. Zanni 1 , G. Taccetti 2 , C. Palleschi 1<br />
1 Dept. of Deve<strong>lo</strong>pmental and Cell Bio<strong>lo</strong>gy, University LA SAPIENZA, Rome, Italy<br />
2 CF Center Tuscany Meyer Hospital, University of F<strong>lo</strong>rence, Italy<br />
38 CALPROTECTIN :AN INFLAMMATORY INTESTINAL MARKER IN CYSTIC<br />
FIBROSIS?<br />
S.Farina, N.Ravenni, MC.Cavicchi, A.Neri, T.Repetto<br />
Regional Cystic Fibrosis Center- AOU Meyer -F<strong>lo</strong>rence Italy<br />
39 PSEUDOMONAS AERUGINOSA PATHOGENICITY WITHIN CLONAL STRAINS<br />
FROM PATIENTS WITH CYSTIC FIBROSIS.<br />
Bragonzi A 1 , Paroni M 1 , Montanari S 1 , Oliver A 2 , Döring G 3 , Tümmler B 4<br />
1<br />
European Institute for Cystic Fibrosis Research, Scientific Institute H.S.Raffaele, Milano,<br />
Italy.<br />
2<br />
Servicio de Microbio<strong>lo</strong>gìa Hospital Son Dureta, Palma de Mal<strong>lo</strong>rca, Spain.<br />
3<br />
Institute of Medical Microbio<strong>lo</strong>gy, Universitätsklinikum Tübingen, Tübingen, Germany.<br />
4<br />
Klinische Forschergruppe Medizinische Hochschule, Hannover, Germany.<br />
40 INHIBITION OF PRO-INFLAMMATORY GENES IN CF BRONCHIAL<br />
EPITHELIAL CELLS BY MEDICINAL PLANT EXTRACTS<br />
Lampronti I 1 , Dechecchi MC 2 , Borgatti M 1 , Nicolis E 2 , Bezzerri V 2 , Mancini I 1 , Tamanini A 2 ,<br />
Quiri F 2 , Rizzotti P 2 , Cabrini G 2 , Gambari R 1<br />
1. Department of Biochemistry and Molecular Bio<strong>lo</strong>gy, University of Ferrara<br />
2. Laboratory of Molecular Patho<strong>lo</strong>gy, Laboratory of Clinical Chemistry and Haemato<strong>lo</strong>gy,<br />
University Hospital of Verona<br />
41 ANTI-INFLAMMATORY EFFECT OF MIGLUSTAT IN BRONCHIAL CELLS<br />
Dechecchi M.C.1; Nicolis E.1; Norez C.1,2, Bezzerri V.1; Tamanini A.1; Quiri1 F.1; Borgatti<br />
M.3; Mancini I.3; Rizzotti P.1; Gambari R.3;Becq F.2and Cabrini G.1<br />
1. Laboratory of Molecular Patho<strong>lo</strong>gy, Laboratory of Clinical Chemistry and Haemato<strong>lo</strong>gy,<br />
University Hospital of Verona, Verona, Italy.<br />
2. Institut de Physio<strong>lo</strong>gie et Bio<strong>lo</strong>gie Cellulaires CNRS, Universite de Poitiers, Poitiers,<br />
France.<br />
3. Department of Biochemistry and Molecular Bio<strong>lo</strong>gy, University of Ferrara, Ferrara, Italy.
42 “DECOY” MOLECULES FOR NUCLEAR TRANSCRIPTION FACTORS AND<br />
REGULATION OF EXPRESSION OF PROINFLAMMATORY GENES<br />
Bezzerri, V. 1 ; Borgatti, M. 2 ; Mancini, I. 2 ; Nicolis, E. 1 ; Dechecchi, M. C. 1 ; Tamanini, A. 1 ;<br />
Quiri, F. 1 ; Lampronti, I. 2 ; Rizzotti, P. 1 ; Gambari, R. 2 ; Cabrini, G. 1<br />
a. Laboratory of Molecular Patho<strong>lo</strong>gy, Laboratory of Clinical Chemistry and Haemato<strong>lo</strong>gy,<br />
University Hospital of Verona, Verona, Italy.<br />
b. Department of Biochemistry and Molecular Bio<strong>lo</strong>gy, University of Ferrara, Ferrara, Italy.<br />
43 EZRIN PHOSPHORYLATION AND ACTIVATION OF RHOA PLAY A ROLE IN<br />
THE RESCUE OF ΔF508CFTR IN CFBE41O- CELLS BY NHERF1<br />
Favia M, Guerra L, Riccardi SM, Fanelli T, Cardone RA, Reshkin SJ, *Conese M, Casavola V.<br />
Dept. of General and Environmental Physio<strong>lo</strong>gy, University of Bari, Italy; * Dept. of<br />
Biomedical Sciences, University of Foggia, Italy<br />
44 SLEEP-DISORDERED BREATHING IN ADULTS AND CHILDREN WITH CYSTIC<br />
FIBROSIS<br />
Lucia Spicuzza, Concetta Sciuto, Giovanna Di Dio, Laura Bivona, Mariacristina Celi, Mario<br />
La Rosa<br />
Broncopneumo<strong>lo</strong>gia Pediatrica, Dipartimento di Pediatria, Università di Catania<br />
45 CORRELATION BETWEEN STATURE AND FEV1: AN ITALIAN MULTI-<br />
CENTRIC STUDY ON 620 CF PATIENTS AGED 6-18 YEARS<br />
Coruzzo A*, Russo B*, Valmarana L*, Guidotti M*, Maglieri M*, Pesola M*, Ravaioli E*,<br />
Beschi S*, Dester S*, Rinaldi D*, Raia V§, Co<strong>lo</strong>mbo Cˇ, Grynzich L˚, Miano A˜, Ratclif Lǿ,<br />
Repetto Tǽ, Tuccio Gǽ, Padoan Rώ, Menicucci LП, Provenzano EФ, Alghisi Fˆ, Siano M§,<br />
De Gregorio F§, Tozzi A°, Lucidi Vˆ<br />
* SIFC Dietician Workgroup;<br />
CF Units: §Napoli, ˇMilano, ˚Parma, ˜Cesena, ǿCerignola, ǽFirenze, ώBrescia, ПGenova,<br />
ФSoverato, ˆRoma Osp. Bambin Gesù;<br />
°UOS of Epidemio<strong>lo</strong>gy, Ospedale Bambin Gesù, Roma<br />
46 COMPARISON AMONG AUXOLOGIC INDEXES TO EVALUATE NUTRITIONAL<br />
STATUS OF PEDIATRIC CF PATIENTS AND CREATION OF CF GROWTH<br />
CHARTS: A MULTI-CENTRIC ITALIAN STUDY<br />
Russo B*, Coruzzo A*, Valmarana L*, Guidotti M*, Maglieri M*, Pesola M*, Ravaioli E*,<br />
Beschi S*, Dester S*, Rinaldi D*, Raia V§, Co<strong>lo</strong>mbo Cˇ, Grynzich L˚, Miano A˜, Ratclif Lǿ,<br />
Repetto Tǽ, Tuccio Gǽ, Padoan Rώ, Menicucci LП, Provenzano EФ, Alghisi Fˆ, Siano M§,<br />
De Gregorio F§, Tozzi A°, Lucidi Vˆ<br />
* SIFC Dietician Workgroup;<br />
CF Units: §Napoli, ˇMilano, ˚Parma, ˜Cesena, ǿCerignola, ǽFirenze, ώBrescia, ПGenova,<br />
ФSoverato, ˆRoma Osp. Bambin Gesù;<br />
°UOS of Epidemio<strong>lo</strong>gy, Ospedale Bambin Gesù, Roma
47 RECURRENT PANCREATITIS AS THE FIRST MANIFESTATION OF CYSTIC<br />
FIBROSIS: A SINGLE CENTRE EXPERIENCE<br />
F. Alghisi 1 , A. Angioni 2 , A. C. Tomaiuo<strong>lo</strong> 2 , M. R. D’Apice 3 , S. Gambar<strong>della</strong> 3 , B. Russo 1 , S.<br />
Bella 1 , P. De Angelis 4 , L. Dall’Oglio 4 , G. Novelli 3 , V. Lucidi 1<br />
1<br />
U.O.S. of Cystic Fibrosis, Bambino Gesù Pediatric Hospital, Rome, Italy<br />
2<br />
Laboratory of Cytogenetics and Molecular Genetics, Bambino Gesù Pediatric Hospital,<br />
Rome, Italy<br />
3<br />
Dept. of Biopatho<strong>lo</strong>gy and Diagnostic Imaging, Tor Vergata University, Rome, Italy<br />
4<br />
Surgical and Endoscopic Digestive Unit, Bambino Gesù Pediatric Hospital, Rome, Italy<br />
48 DOES CYCLOSPORINE TREATMENT MAY AFFECT CYSTIC FIBROSIS<br />
PULMONARY DISEASE? A CASE REPORT<br />
De Robertis Francesco, Tesse Riccardina, Manca Antonio, Abrusci Maria Raffaella, Lauria<br />
Barbara, Capo<strong>lo</strong>ngo Arcangela, Quarta Valentina, Dermyshi Elda, Armenio Lucio.<br />
Department of Biomedicina dell’Età Evolutiva, Pediatric Unit “S. Maggiore”, University of<br />
Bari, Italy.<br />
49 TELEMONITORING FEV1 AND PEF IN CYSTIC FIBROSIS PATIENTS VERSUS<br />
FPR AMBULATORY<br />
Antonio Manca, Valentina Bosco, Marilena Malvasi, Monica Lorusso, Lucio Armenio.<br />
Centro Specializzato di Riferimento Pugliese <strong>per</strong> la Fibrosi Cistica, U.O. “S. Maggiore”<br />
Università di Bari, Bari.<br />
50 ATYPCAL CYSTIC FIBROSIS (ACF): AN EXPERIENCE OF A CYSTIC FIBROSIS<br />
CENTER<br />
M. Siano*, R. Tomaiuo<strong>lo</strong>**, F. De Gregorio*, A. Sepe*, P. Ferri*, A. Elce **, G. Castaldo**<br />
and V. Raia*<br />
* Dep. of Pediatrics, ** Dep. of Biochemistry and Medical Biotecno<strong>lo</strong>gy, Univ. of Naples<br />
Federico II-CEINGE, Italy.<br />
51 ANALYSIS OF FACTORS PROMOTING BONE DISEASE IN CYSTIC FIBROSIS<br />
Antonio Manca, Francesco De Robertis, Barbara Formato, Barbara Lauria, Valentina Quarta,<br />
Elda Dermyshi, Riccardina Tesse, Lucio Armenio<br />
Centro Specializzato di Riferimento Pugliese <strong>per</strong> la Fibrosi Cistica, U.O. “S. Maggiore”<br />
Università di Bari, Bari.<br />
52 ROLE OF INFECTIOUS PULMONARY COMPLICATIONS IN LUNG<br />
TRANSPLANTATION FOR CYSTIC FIBROSIS: 10 YEARS FOLLOW – UP<br />
L. Locorriere, C. Scacchi, M. Trancassini, A. Magni, G. Cimino, S. Quattrucci.<br />
Cystic Fibrosis Center, Department of Pediatrics, “Sapienza” University of Rome
53 COLONIC CARCINOMA ON FC PATIENT<br />
M. Collura°, G. Traverso° F. Ficili°, V. Di Pietrantonio°, T. Pensabene°, P.E. Marchesa٭, F.<br />
Pardo°<br />
° U.O. II Pediatria-Fibrosi Cistica Osp “G. Di Cristina” ARNAS-Civico Palermo<br />
٭Dipart. Chirurgie ed Onco<strong>lo</strong>gia ARNAS – Civico Palermo<br />
54 NUTRITIONAL AND RESPIRATORY EFFECTS OF AZITHROMYCIN LONG-<br />
TERM TREATMENT IN CYSTIC FIBROSIS PATIENTS.<br />
MC Tripodi, GL Grzincich, R Minari, S Dall’Aglio, G Pisi<br />
Cystic Fibrosis Unit, Dep. of Pediatrics, Parma, Italy<br />
55 ACHROMOBACTER XYLOSOXIDANS: FOLLOWUP OF 20 PATIENTS WITH<br />
CHRONIC INFECTION.<br />
D. Costantini^, A.Biffi*, M.L. Garlaschi**, L. Zazzeron^, G. Clarizia**C. Co<strong>lo</strong>mbo^,L.<br />
Cariani.*<br />
* CF Centre, Microbio<strong>lo</strong>gy Laboratory, Fondazione IRCCS, Ospedale Maggiore Policlinico,<br />
Mangiagalli e Regina Elena. ( Milano).<br />
** Microbio<strong>lo</strong>gy Laboratory, Fondazione IRCCS, Ospedale Maggiore Policlinico,<br />
Mangiagalli e Regina Elena. ( Milano).<br />
^ CF Centre, Department of Pediatrics,University of Milan<br />
^^ Centre, Fondazione IRCCS, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena<br />
(Milano).<br />
56 OXIDATIVE STATUS CHANGE IN CYSTIC FIBROSIS (CF) AND ORAL<br />
ADDITION WITH WHEY PROTEIN ISOLATE WITH HIGH CONTENT OF<br />
CYSTEINE: PRELIMINARY OBSERVATIONS<br />
S.Beschi,L.Minicucci,R.Casciaro,C.Zucchi,M.Haupt,S.Pessano,T.Mora,A.De Alessandri.<br />
Regional Cystic Fibrosis Centre , G.Gaslini Institute, Genoa,Italy<br />
57 CYTOKINE PROFILES IN DIFFERENT MATRIXES (SERUM, SPUTUM AND<br />
EXALATE) OF CYSTIC FIBROSIS PATIENTS<br />
Faelli N 1 Tirelli A.S., 2 Conese M., 3 Costantini D, 1 Biffi A, 1 MottaV, 1 Co<strong>lo</strong>mbo C 1<br />
1 Cystic Fibrosis Centre and 2 Laboratory of Clinical Patho<strong>lo</strong>gy, Fondazione IRCSS<br />
Policlinico Ospedale Maggiore;Mangiagalli, Regina Elena, Milan; 3 Institute for the<br />
Ex<strong>per</strong>imental Treatment of Cystic Fibrosis, H.S. Raffaele, Milan, Italy.
58 CYSTIC FIBROSIS RELATED DIABETES IS ANTICIPATED BY REDUCED<br />
INSULIN SECRETION DURING OGTT.<br />
Alberto Battezzati 1, 2 ; Pier Maria Battezzati 3 ; Diana Costantini 2 ; Laura Zazzeron 2 ; Maria<br />
Chiara Russo 2 ; Valeria Daccò 2 ; Valentina Motta 2 ; Carla Co<strong>lo</strong>mbo 2<br />
1. ICANS - DiSTAM, University of Milan, Milano, Italy.<br />
2. CF Center, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli, Regina<br />
Elena, University of Milan, Milano, Italy.<br />
3. Dept of Medicine, Surgery and Dentistry, Università degli Studi di Milano, Milano, Italy.<br />
59 CONTINUOUS SUBCUTANEOUS GLUCOSE MONITORING IN CYSTIC<br />
FIBROSIS (CF) PATIENTS<br />
F. Patriarchi, A Menichella, F. Costantino, R. Scrocca, S. Bertasi, S Quattrucci.<br />
Cystic Fibrosis Center, Department of Pediatrics, “Sapienza” University of Rome<br />
60 EXEPTIONALLY EARLY OCCURRENCE OF EBV RELATED LYMPHOMA<br />
AFTER LUNG TRANSPLANTATION<br />
V. D’Alù, M.Rolla, A.Menichella, F.Patriarchi, L.Locorriere, C.Scacchi, D.Russo, P.Troiani,<br />
S.Quattrucci<br />
Cystic Fibrosis Center, Department of Pediatrics, “Sapienza” University of Rome<br />
61 TOTIRESISTENT BURKHOLDERIA CEPACIA COMPLEX SEPSIS IN A 62 YEARS<br />
OLD WOMAN WITH CYSTIC FIBROSIS<br />
Antonelli A, Balteri I, Schreiber A, Grosso B, Messore B, De Rose V.<br />
Centro Regionale <strong>per</strong> la Fibrosi Cistica Piemonte e Valle d’Aosta - Settore Adulti<br />
Clinica di Malattie dell’Apparato Respiratorio - Università degli Studi di Torino<br />
Azienda Ospedaliera San Luigi Gonzaga, Orbassano (Torino)<br />
62 FUNCTIONAL ENDOSCOPIC SINUS SURGERY (FESS) IN PATIENTS WITH<br />
CYSTIC FIBROSIS (CF)<br />
C. Scacchi, L. Locorriere, V. Savastano, F. Zardo, D. Russo, S. Bertasi.<br />
Cystic Fibrosis Center, Department of Pediatrics, “Sapienza” University of Rome<br />
63 CLOSTRIDIUM DIFFICILE (CD) COLITIS IN CF LUNG TRANSPLANTED<br />
PATIENT<br />
Alessandra Menichella, Matilde Rolla, Patrizia Troiani, Francesca Patriarchi, Serena<br />
Quattrucci<br />
Cystic Fibrosis Center,Department of Pediatrics, “Sapienza” University of Rome<br />
64 LONG TERM FOLLOW-UP OF A CYSTIC FIBROSIS (CF) PATIENT WITH<br />
PREVIOUS NEUROBLASTOMA<br />
Casciaro R., Haupt M., Pessano S. , Caso M., Bergamino L., Minicucci L., Lorini R.<br />
Department of Pediatrics – CF Centre, G. Gaslini Institute - Genova - Italy
65 LUNG EXACERBATION IN A CYSTIC FIBROSIS (CF) PATIENT CAUSED BY A<br />
MULTIRESISTANT EXTENDED SPECTRUM Β-LACTAMASE (ESBL)<br />
PRODUCING STRAIN OF ESCHERICHIA COLI (EC).<br />
Casciaro R. 1 , Pessano S. 1 ,Ambrosini L. 1 , Caso M. 1 , Manno G. 2 , Mentasti M. 2 , Morelli P. 2 ,<br />
Minicucci L. 1 , Lorini R. 1 .<br />
1 2<br />
Department of Pediatrics – CF Centre, General Laboratory of Analisys, G. Gaslini<br />
Institute - Genova - Italy<br />
66 POSITIVE LUNG I-131 WHOLE SCAN IN A THYROIDECTOMIZED CYSTIC<br />
FIBROSIS PATIENT FOR THYROID CANCER: CYSTIC FIBROSIS PULMONARY<br />
INVOLVEMENT OR THYROID METASTASIS?<br />
Maddalena Zanardelli, Giovanna Pizzamiglio, Maria Alice Monti, Natale Gervasini,<br />
Francesco Blasi. Adult Cystic Fibrosis Center, Bronchopneumo<strong>lo</strong>gy Unit, Ospedale Maggiore<br />
Policlinico, Mangiagalli e Regina Elena, Milan, Italy.<br />
67 SPHENOID SINUS MUCOCELE IN A CYSTIC FIBROSIS CHILD<br />
Di Cicco M.*, Ferrario F., Costantini D., Co<strong>lo</strong>mbo C.<br />
* ENT Department – Pediatrics Department - CF Centre Fondazione IRCCS “Ospedale<br />
Maggiore Policlinico, Mangiagalli e Regina Elena” – University of Milan, Milan (Italy)<br />
68 CISTIC FIBROSIS PATIENT WITH SEVERE RESPIRATORY FAILURE: RAPID<br />
RESOLUTION OF ATELECTASIS WITH NIMV.<br />
Maria Alice Monti, Maddalena Zanardelli, Natale Gervasini, Giovanna Pizzamiglio,<br />
Francesco Blasi. Adult Cystic Fibrosis Center, Bronchopneumo<strong>lo</strong>gy Unit, Ospedale Maggiore<br />
Policlinico, Mangiagalli e Regina Elena, Milan, Italy.<br />
69 PULMONARY MALFORMATION AND CYSTIC FIBROSIS (CF): WHICH<br />
DIAGNOSIS, HOW TO TREAT AND TIMING OF PROCEDURE (CASE REPORT).<br />
R.Padoan1, V. Bennato1, S. De Leone1, G.Battaglia2, R. Maroldi2, D. Falchetti3<br />
1. Cystic Fibrosis Service, AO Spedali Civili, Brescia<br />
2. Department of Radio<strong>lo</strong>gy, University of Brescia<br />
3. Paediatric Surgery, AO Spedali Civili, Brescia<br />
70 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN CYSTIC<br />
FIBROSIS.<br />
A.Nigro, P.Vitul<strong>lo</strong>, L.Ratclif<br />
U.O.S. Cystic Fibrosis- Cerignola (FG)<br />
71 CF NEWBORN SCREENING AND ITS PREVENTIVE EFFECT: 7 YEARS<br />
EXPERIENCE IN THE UMBRIA REGION<br />
A.Angius, M.Stasi, T. Becchetti, M.C.Cardellini, L.Penta, M. Furbetta<br />
Lab. di Genetica Molecolare, Clinica Pediatrica, Università di Perugia
72 NEONATAL SCREENING FOR CYSTIC FIBROSIS IN EMILIA ROMAGNA:<br />
EVALUATION OF CLINICAL PARAMETERS, FUNCTIONAL AND<br />
INSTRUMENTAL OF TWO POPULATIONS AFFECTED BY THE DISEASE, AGE<br />
COMPARISON BETWEEN PRE AND POSTSCREENING.<br />
F. Bernardi, M. Bucci, M. Ambroni, C. Spaggiari,G. Grzincich, A. Miano, F. Battistini<br />
Department of Paediatrics Hospital in Bo<strong>lo</strong>gna, Cesena and Parma Italy<br />
73 MEASUREMENT OF PANCREATITIS-ASSOCIATED PROTEIN IN<br />
COMBINATION TO IMMUNOREACTIVE TRYPSINOGEN FOR NEONATAL<br />
SCREENING STRATEGY OF CF: A MULTICENTER FEASIBILITY STUDY<br />
Vigano P. 1 , Corbetta C. 1 , Mariani T. 1 , Cattaneo C. 1 , Björklund C. 2 , Kasel M. 2 , Karvonen H. 2 ,<br />
Hoffman G.H. 3 , Laessig R.H. 3 , Kopish G.J. 3 , Eaton R. 4 , Comeau A. 4 , Stopsack M. 5 ,<br />
Hammermann J. 5 , Nilson N. 5 , Heine C. 5 , Fenner J. 5 , Dagorn J.C 6 .<br />
1 Laboratorio di Riferimento Regionale <strong>per</strong> <strong>lo</strong> Screening Regionale, A.O. Istituti Clinici di<br />
Perfezionamento, Milano; PerkinElmer, Inc., Wallac Oy, Turku, Finland; 3 Wisconsin State<br />
Laboratory of Hygiene, University of Wisconsin, Madison, Wisconsin, USA; 4 New England<br />
Newborn Screening Program, University of Massachusetts, MA, USA; 5 Kinder- und<br />
Frauenzentrum Universitatsklinikum Carl Gustaf Carus Stoffwechsel- und Screeninglabor,<br />
Dresden, Germany; 6 Dynabio S.A. Marseille, France